Melanoma patients monitored for Long-Term effects after experimental drug combo
NCT ID NCT06848088
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 48 people with advanced melanoma who previously received the experimental drugs fianlimab and cemiplimab in an earlier study. No new treatment is given; instead, researchers track their health, cancer status, and any late side effects over time. The goal is to understand the long-term safety and effectiveness of the drug combination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Pacific Medical Center
San Francisco, California, 94115, United States
-
Cancer & Hematology Centers of Western Michigan
Grand Rapids, Michigan, 49546, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
South Texas Oncology And Hematology
San Antonio, Texas, 78229, United States
-
St. Vincent's University Hospital
Dublin, D04 T6F4, Ireland
-
The Angeles Clinic and Research Institute - West Los Angeles Office
Los Angeles, California, 90025, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States